1,944 research outputs found
Avionics System and Attitude Algorithms for a Deorbit Device Based on an Electrodynamic Tether
The main goal of the Electrodynamic Tether technology for PAssive Consumable-less deorbit Kit (E.T.PACK) project is to develop a deorbit device based on an electrodynamic tether with TRL 4 by 2022. In September 2022, its continuation, i.e. the E.T.PACK-F project, will carry on with the activities of E.T.PACK to prepare a flight model with TRL 8 that will be tested in an in-orbit demonstration mission in 2025. This work (i) describes the attitude determination and control strategy of the mission, which is used as a means of explaining its different phases and the dynamics of each one of them, (ii) provides a description of the avionics elements of the whole system, (iii) describes some of the tests performed until this moment, and (iv) summarizes the current status and the future work
Recommended from our members
Length of migration and eating habits of Portuguese university students living in London, United Kingdom
Several studies have pointed adverse effects of long term migration on eating habits. Research is needed to understand if this effect occurs also with a short length of migration, as is the case of international students. Our aim was to evaluate the effect of short and long term migration on eating habits of Portuguese university students. Participants were 46 English and 55 Portuguese students from universities in London, United Kingdom. The findings from this study highlight the difficulties that Portuguese students faced in maintaining a traditional Mediterranean diet after moving to a Northern European environment
Interstellar abundances in the neutral and ionized gas of NGC604
We present FUSE spectra of the giant HII region NGC604 in the spiral galaxy
M33. Chemical abundances are derived from far-UV absorption lines and are
compared to those derived from optical emission lines. We derived the column
densities of HI, NI, OI, SiII, PII, ArI, and FeII, fitting the line profiles
with either a single component or several components. Our net results, assuming
a single component, show that N, O, Si, and Ar are apparently underabundant in
the neutral phase by a factor of 10 or more with respect to the ionized phase,
while Fe is the same. However, we discuss the possibility that the absorption
lines are made of individual unresolved components, and find that only PII,
ArI, and FeII lines should not be affected by the presence of hidden saturated
components, while NI, OI, and SiII might be much more affected. If N, O, and Si
are actually underabundant in the neutral gas of NGC604 with respect to the
ionized gas, this would confirm earlier results obtained for the blue compact
dwarfs. However, a deeper analysis focused on P, Ar, and Fe mitigates the above
conclusion and indicates that the neutral gas and ionized gas could have
similar abundances.Comment: Accepted for publication in A&
Plasma miRNA profile at COVID-19 onset predicts severity status and mortality
BACKGROUND: MicroRNAs (miRNAs) have a crucial role in regulating immune response against infectious diseases, showing changes early in disease onset and before the detection of the pathogen. Thus, we aimed to analyze the plasma miRNA profile at COVID-19 onset to identify miRNAs as early prognostic biomarkers of severity and survival. METHODS AND RESULTS: Plasma miRNome of 96 COVID-19 patients that developed asymptomatic/mild, moderate and severe disease was sequenced together with a group of healthy controls. Plasma immune-related biomarkers were also assessed. COVID-19 patients showed 200 significant differentially expressed (SDE) miRNAs concerning healthy controls, with upregulated putative targets of SARS-CoV-2, and inflammatory miRNAs. Among COVID-19 patients, 75 SDE miRNAs were observed in asymptomatic/mild compared to symptomatic patients, which were involved in platelet aggregation and cytokine pathways, among others. Moreover, 137 SDE miRNAs were identified between severe and moderate patients, where miRNAs targeting the SARS CoV-2 genome were the most strongly disrupted. Finally, we constructed a mortality predictive risk score (miRNA-MRS) with ten miRNAs. Patients with higher values had a higher risk of 90-days mortality (hazard ratio = 4.60; p-value < 0.001). Besides, the discriminant power of miRNA-MRS was significantly higher than the observed for age and gender (AUROC = 0.970 vs. 0.881; p = 0.042). CONCLUSIONS: SARS-CoV-2 infection deeply disturbs the plasma miRNome from an early stage of COVID-19, making miRNAs highly valuable as early predictors of severity and mortality
Newborn screening for presymptomatic diagnosis of complement and phagocyte deficiencies
The clinical outcomes of primary immunodeficiencies (PIDs) are greatly improved by
accurate diagnosis early in life. However, it is not common to consider PIDs before
the manifestation of severe clinical symptoms. Including PIDs in the nation-wide
newborn screening programs will potentially improve survival and provide better disease
management and preventive care in PID patients. This calls for the detection of
disease biomarkers in blood and the use of dried blood spot samples, which is a part
of routine newborn screening programs worldwide. Here, we developed a newborn
screening method based on multiplex protein profiling for parallel diagnosis of 22 innate
immunodeficiencies affecting the complement system and respiratory burst function in
phagocytosis. The proposed method uses a small fraction of eluted blood from dried
blood spots and is applicable for population-scale performance. The diagnosis method
is validated through a retrospective screening of immunodeficient patient samples. This
diagnostic approach can pave the way for an earlier, more comprehensive and accurate
diagnosis of complement and phagocytic disorders, which ultimately lead to a healthy
and active life for the PID patientsThis work was supported by the Swedish Research Council
(VR) and grants provided by the Stockholm County
Council (ALF)
Sarcoma treatment in the era of molecular medicine
Sarcomas are heterogeneous and clinically challenging soft tissue and bone cancers. Although constituting only 1% of all human malignancies, sarcomas represent the second most common type of solid tumors in children and adolescents and comprise an important group of secondary malignancies. More than 100 histological subtypes have been characterized to date, and many more are being discovered due to molecular profiling. Owing to their mostly aggressive biological behavior, relative rarity, and occurrence at virtually every anatomical site, many sarcoma subtypes are in particular difficult-to-treat categories. Current multimodal treatment concepts combine surgery, polychemotherapy (with/without local hyperthermia), irradiation, immunotherapy, and/or targeted therapeutics. Recent scientific advancements have enabled a more precise molecular characterization of sarcoma subtypes and revealed novel therapeutic targets and prognostic/predictive biomarkers. This review aims at providing a comprehensive overview of the latest advances in the molecular biology of sarcomas and their effects on clinical oncology; it is meant for a broad readership ranging from novices to experts in the field of sarcoma.Peer reviewe
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose exposures to mixtures of chemicals in the environment may be combining to contribute to environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple priority target sites for disruption in each area and prototypical chemical disruptors for all targets, this included dose-response characterizations, evidence of low-dose effects and cross-hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were reviewed for actions on key pathways/mechanisms related to carcinogenesis. Only 15% (13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) exerted low-dose effects. No dose-response information was found for the remaining 26% (22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) chemicals acting on different pathways, and a variety of related systems, organs, tissues and cells could plausibly conspire to produce carcinogenic synergies. Additional basic research on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be rigorously pursued before the merits of this hypothesis can be further advanced. However, the structure of the World Health Organization International Programme on Chemical Safety 'Mode of Action' framework should be revisited as it has inherent weaknesses that are not fully aligned with our current understanding of cancer biology
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context
Long noncoding RNAs (lncRNAs) are commonly dys-regulated in tumors, but only a handful are known toplay pathophysiological roles in cancer. We inferredlncRNAs that dysregulate cancer pathways, onco-genes, and tumor suppressors (cancer genes) bymodeling their effects on the activity of transcriptionfactors, RNA-binding proteins, and microRNAs in5,185 TCGA tumors and 1,019 ENCODE assays.Our predictions included hundreds of candidateonco- and tumor-suppressor lncRNAs (cancerlncRNAs) whose somatic alterations account for thedysregulation of dozens of cancer genes and path-ways in each of 14 tumor contexts. To demonstrateproof of concept, we showed that perturbations tar-geting OIP5-AS1 (an inferred tumor suppressor) andTUG1 and WT1-AS (inferred onco-lncRNAs) dysre-gulated cancer genes and altered proliferation ofbreast and gynecologic cancer cells. Our analysis in-dicates that, although most lncRNAs are dysregu-lated in a tumor-specific manner, some, includingOIP5-AS1, TUG1, NEAT1, MEG3, and TSIX, synergis-tically dysregulate cancer pathways in multiple tumorcontexts
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Although theMYConcogene has been implicated incancer, a systematic assessment of alterations ofMYC, related transcription factors, and co-regulatoryproteins, forming the proximal MYC network (PMN),across human cancers is lacking. Using computa-tional approaches, we define genomic and proteo-mic features associated with MYC and the PMNacross the 33 cancers of The Cancer Genome Atlas.Pan-cancer, 28% of all samples had at least one ofthe MYC paralogs amplified. In contrast, the MYCantagonists MGA and MNT were the most frequentlymutated or deleted members, proposing a roleas tumor suppressors.MYCalterations were mutu-ally exclusive withPIK3CA,PTEN,APC,orBRAFalterations, suggesting that MYC is a distinct onco-genic driver. Expression analysis revealed MYC-associated pathways in tumor subtypes, such asimmune response and growth factor signaling; chro-matin, translation, and DNA replication/repair wereconserved pan-cancer. This analysis reveals insightsinto MYC biology and is a reference for biomarkersand therapeutics for cancers with alterations ofMYC or the PMN
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
This integrated, multiplatform PanCancer Atlas study co-mapped and identified distinguishing
molecular features of squamous cell carcinomas (SCCs) from five sites associated with smokin
- …